Clinical trial

Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of…

NCT00491894 · Shionogi, Industry · Completed

Key facts

NCT number NCT00491894
Title Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
Official title A Six-Month, Multi-Center, Open-Label Study to Assess the Safety and Efficacy of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
Lead sponsor Shionogi, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cerebral Palsy, Neurological Conditions, Mental Retardation, Sialorrhea
Intervention type Drug
Interventions Oral Glycopyrrolate Liquid
Enrollment 137
Start date Mar 1, 2007
Primary completion May 1, 2008
Completion Jun 1, 2008
First posted Jun 26, 2007
Last update posted Jul 9, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies